Similar to the organizations’ Heart Care Plus+ initiative which took effect March 1, the Cancer Care Plus+ collaboration is designed to enhance both organizations’ commitment to population health management and the delivery of accessible, value-based cancer care. The organizations will remain independent entities.
The collaboration will be anchored at Duke Raleigh (N.C.) Hospital and will combine the health system’s cancer research programs and services with the surgical cancer capabilities of WakeMed’s area hospitals.
“Working together with our colleagues at Duke to streamline, enhance and expand the delivery of oncology care in Wake County is an exciting development that meets a critical need for patients, caregivers and the communities we serve,” said Donald Gintzig, president and CEO of WakeMed Health & Hospitals. “This agreement supports both WakeMed and Duke’s commitment to improving the scope, quality and value of care we offer to our patients and their families through innovative and cooperative collaborations with like-minded organizations.”
More articles on transactions and valuations:
Alecto Healthcare Services files request to declare Ohio medical center ‘financially distressed’ to complete purchase
Abbott renegotiates deal with Alere, shaves $500M off original price
7 recent hospital transactions and partnerships
